Target Name: FGF3
NCBI ID: G2248
Other Name(s): INT-2 proto-oncogene protein | Fibroblast growth factor 3 | murine mammary tumor virus integration site 2, mouse | FGF-3 | fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) | INT2 | proto-oncogene Int-2 | HBGF-3 | Proto-oncogene Int-2 | heparin-binding growth factor 3 | V-INT2 murine mammary tumor virus integration site oncogene homolog | Heparin-binding growth factor 3 | INT-2 proto-oncogene protein precursor | oncogene INT2 | FGF3_HUMAN | fibroblast growth factor 3

FGF3: A Key Regulator of Cell Proliferation and Survival

FGF3 (FGF-3), a protein that belongs to the family of growth factors, is a key regulator of cell proliferation and survival. It is expressed in various tissues and cell types, including neural, epithelial, and embryonic cells. FGF3 plays a crucial role in the development and maintenance of tissues and organs, as well as in tissue repair and regeneration.

Due to its unique function and its involvement in several biological processes, FGF3 has been identified as a potential drug target and biomarker. In this article, we will explore the biology of FGF3, its functions in various tissues, and its potential as a drug target.

FGF3 biology

FGF3 is a 21-kDa transmembrane protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is involved in the formation of the protein's transmembrane structure, while the transmembrane domain is responsible for the protein's proper localization and interactions with other cells. The intracellular domain is involved in the protein's interaction with various signaling pathways and targets.

FGF3 is involved in several critical biological processes, including cell proliferation, differentiation, migration, and survival. It is a potent regulator of cell growth, and its levels have been shown to play a role in the regulation of cell proliferation, apoptosis, and angiogenesis.

FGF3 is also involved in the regulation of cell-cell interactions and tissue architecture. It has been shown to play a role in the development and maintenance of tissues and organs, including the neural system, epithelial tissue, and placenta. Additionally, FGF3 is involved in tissue repair and regeneration, as it has been shown to promote the proliferation and differentiation of stem cells.

FGF3 signaling

FGF3 has several signaling pathways that involve its involvement in the regulation of cellular processes. One of the most well-studied signaling pathways is the FGF signaling pathway. This pathway involves the interaction between FGF and its receptor, FGFR1. in the regulation of cell growth, differentiation, and survival, as well as in the regulation of cell-cell interactions and tissue architecture.

The FGF signaling pathway involves several downstream targets, including the transcription factors SFP1/HFG, AP-1, and NF-kappa-B. These transcription factors are involved in the regulation of cellular processes such as cell growth, apoptosis, and angiogenesis.

FGF3 as a drug target

FGF3 has been identified as a potential drug target due to its involvement in several biological processes that are associated with the development and treatment of various diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of cell growth and apoptosis.

FGF3 has been shown to promote the growth and survival of cancer cells, which makes it an attractive target for anti-cancer drugs. Additionally, FGF3 has been shown to play a role in the regulation of cell apoptosis, which is a critical mechanism that helps cells remove damaged or unnecessary proteins.

FGF3 has also been shown to be involved in the regulation of cellular interactions and tissue architecture, which makes it an attractive target for drugs that are aimed at modulating these processes. For example, FGF3 has been shown to play a role in the regulation of neural development and plasticity, which makes it an attractive target for drugs that are aimed at modulating these processes.

FGF3 as a biomarker

FGF3 has also been identified as a potential biomarker for several diseases. For example, FGF3 has been shown to be involved in the regulation of fetal development and placenta development, which makes it an attractive target for biomarkers that are aimed at detecting fetal abnormalities. Additionally , FGF3 has

Protein Name: Fibroblast Growth Factor 3

Functions: Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal ear development

More Common Targets

FGF4 | FGF5 | FGF6 | FGF7 | FGF7P3 | FGF7P5 | FGF7P6 | FGF8 | FGF9 | FGFBP1 | FGFBP2 | FGFBP3 | FGFR1 | FGFR1OP2 | FGFR2 | FGFR3 | FGFR3P1 | FGFR4 | FGFRL1 | FGG | FGGY | FGL1 | FGL2 | FGR | FH | FHAD1 | FHDC1 | FHF Complex | FHIP1A | FHIP1B | FHIP2A | FHIP2B | FHIT | FHL1 | FHL2 | FHL3 | FHL5 | FHOD1 | FHOD3 | FIBCD1 | FIBIN | FIBP | Fibrinogen | Fibroblast growth factor (FGF) | Fibroblast Growth Factor Receptor (FGFR) | Fibronectin Type III Domain | FICD | FIG4 | FIGLA | FIGN | FIGNL1 | FIGNL2 | FILIP1 | FILIP1L | FILNC1 | FIP1L1 | FIRRE | FIS1 | FITM1 | FITM2 | Five friends of methylated CHTOP complex | FIZ1 | FJX1 | FKBP10 | FKBP11 | FKBP14 | FKBP15 | FKBP1A | FKBP1A-SDCBP2 | FKBP1B | FKBP1C | FKBP2 | FKBP3 | FKBP4 | FKBP5 | FKBP6 | FKBP7 | FKBP8 | FKBP9 | FKBP9P1 | FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945